Please check out the posters at the SNO conference Thursday November 16th-Sunday November 19th, 2023.
Dr. Pedro Lowenstein/Anna Argento-“Brain tumors: from oncostreams to active liquid crystals”.
Dr. Andrea Comba- “Targeting tumor-associated Smooth Muscle Actin (ACTA2) expression in mouse pre-clinical glioma models reduces tumor progression and extends survival”.
Brandon McClellan-“Mutant isocitrate dehydrogenase 1 in glioma causes a reduction in adenosinergic pathway signaling within the tumor microenvironment”.
Dr. Fisal Syed-“Targeting the collagen receptor DDR1 promotes anti-glioma immunity by remodeling collagen fiber architecture”.
Devarshi Mukherji-“Uncovering Mechanisms of Resistance in Pediatric High-Grade Glioma (pHGG)”.
Dr. Maria L. Varela- “First-in-human transgene detection 17 months post-adenoviral therapy”.
Dr. Santiago Haase- “A transcriptionally active epigenetic imprinting of the JAK/STAT pathway mediated by H3.3-G34 mutations in pediatric high-grade glioma (pHGG) induces an immunoreactive TME.”
Dr. Maria L. Varela- “TMIC-16 – The collagen receptor LAIR-1 alters the glioma microenvironment and regulates tumor aggressive behavior”.